30 Benefits of CBD (Effects & Uses)
Can the use of CBD oil benefit you or your loved ones? In this guide, we will summarize and simplify the effects of CBD so that you can see the benefits of CBD for 30 health conditions. If you are looking for a more general overview of CBD oil, check out our CBD Intro Guide or What is CBD.
Note: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
What is CBD & What are the benefits
CBD (cannabidiol) is becoming popular due to its potential benefits for many health conditions. It is a natural chemical in the cannabis plant (hemp or marijuana). Cannabidiol is safe, non-addictive, legal, and doesn’t get you high.
There are 85+ special chemicals found in cannabis plants called cannabinoids. The most well-known are: Cannabidiol (CBD) and Tetrahydrocannabinol (THC). But, CBD and THC interact with receptors in the human body in drastically different ways. Both of these chemicals act on the endocannabinoid system (ECS), a system of receptors throughout the human body and brain.
THC binds to ECS receptors, whereas CBD indirectly regulates the receptors and manages how they respond to other chemicals (see image below). This difference causes the “high” of THC while allowing CBD to provide a long list of health and wellness benefits.
The endocannabinoid system is made of three parts: cell receptors, cannabinoids (naturally made chemicals in the body and those that come from cannabis plants), and enzymes. These receptors are located throughout the entire body and are one of the main signaling channels to help the body respond to stimuli such as inflammation, body temperature, anxiety, and pain.
cbd oil benefits list
There are stories of people trying CBD oil and experiencing a wide range of physical and mental health benefits. The list of reasons that people use CBD for is much longer than the list of the 30 conditions in this article. With all the optimism for CBD, the amount of research into CBD’s benefits is expected to grow in the next few years. However, we only want to highlight conditions that currently have scientific research. Although more clinical research is needed to prove CBD as a treatment for these specific health conditions, there is significant evidence for this list of cbd oil benefits.
Mental health benefits of CBD
CBD has the potential to provide benefits for mental health without intoxicating effects. For people with mental health disorders, their symptoms can impact the quality of life. While there are many methods of addressing mental health, such as therapy and prescription medications, using CBD is a popular alternative. Surveys show the most popular use of CBD products in 2018 was for mental health. Evidence from over 1000 studies* supports using CBD for mental health. However, it is required to note that research on CBD for mental health is still in its early stages, and more studies are necessary.
According to the Anxiety and Depression Association of America*, more than 40 million people in the United States suffer from anxiety disorders. Most people feel anxiety at some point. It can be expressed as being nervous, stressed, or fear. Anxiety is a common symptom of many mental health disorders. Common conditions that fall under anxiety disorders include obsessive-compulsive disorder (OCD), phobias, generalized anxiety disorder, panic disorder, and social anxiety disorder (SAD).
Recent scientific reviews demonstrate the potential of CBD for everyday anxiety and daily stressors. A medical review* by four members of the NYU School of Medicine states that CBD improves anxiety control for Generalized Anxiety Disorder, Panic Disorder, Social Anxiety Disorder, Post-traumatic Stress Disorder, and Obsessive-Compulsive Disorder.
A study* using brain imaging found that CBD reduces anxiety in individuals with a generalized social anxiety disorder. The brain scans signaled that CBD’s benefits are caused by changes in the chemical uptake and blood flow in the brain. CBD can help people suffering from anxiety disorders by impacting the CB1 receptors in the brain and altering the signaling of serotonin receptors. A 2010 study* showed that the effects of CBD on areas of the brain reduced anxiety caused by a social anxiety disorder.
Depression is actually the most commonly diagnosed mental health issue in the world. The CDC* estimates that nearly 50,000 Americans commit suicide each year due to depression.
In research studies, CBD has been effective in helping depression. According to a study* published in the Journal of Neuropharmacology, “CBD could represent a novel fast antidepressant drug, via enhancing both serotonergic and cortical glutamate signaling through a 5-HT1A receptor-dependent mechanism.” The research showed that CBD helps to manage the level of serotonin, which is key to a person’s sense of well-being.
In a 2018 study*, animals were given doses of CBD 24 hours before testing, and this had a rapid antidepressant effect lasting up to one week. This would be a strong improvement as most current pharmaceutical anti-depressants do not have as quick of an effect on depression symptoms.
CBD can also be used to support other options by managing symptoms of depression and mood disorders such as anxiety, low appetite, insomnia, excessive fear, and poor concentration. Additionally, studies* have shown that when CBD is used in combination with selective serotonin reuptake inhibitors (SSRIs), a common type of anti-depressive medication, it increased the effectiveness in relieving depression.
3) Autism Spectrum Disorder
The U.S. Center for Disease Control and Prevention* states that 1 in every 59 children have an Autism Spectrum Disorder. ASD causes communication, behavioral, and social challenges that reduce the patient’s quality of life. So the benefits of CBD for ASD have been covered widely in new stories featured on FOX News*, ABC News*, and USA Today*, where parents show their personal experiences with CBD oil. This is because cannabidiol is said to counteract some of the symptoms of ASD, including aggression, motor impairment, social anxiety, seizures, and sleep problems. But is there evidence?
According to a study* published in the Journal of Neurology, CBD helped relieve problematic behavior in Autistic children with a success rate of 80%. Plus, the findings of a recent study* demonstrated that CBD improved behavioral outbreaks, communication problems, anxiety, stress, and disruptive behavior in children with autism.
4) Attention-Deficit Hyperactivity Disorder (ADHD)
According to a paper* in the Journal of the American Academy of Child & Adult Psychiatry, ~6.1% of children in the United States are diagnosed with Attention-Deficit Hyperactivity Disorder (ADHD). Although the neurodevelopmental disorder is often found in children, it lasts into adulthood. Common symptoms include compulsive behavior, short-term memory challenges, and issues paying attention.
What are the uses of CBD for ADHD? A study*, in the Journal of European Neuropsychopharmacology, concluded that CBD is an effective for ADHD. The patients showed improvements in their impulsivity, quality of sleep, and level of concentration. One study*, on adults with ADHD, stated the following conclusion. “While not definitive, this study provides preliminary evidence supporting the self-medication theory of cannabis (including CBD) use in ADHD and the need for further studies of the endocannabinoid system in ADHD.”
5) Post Traumatic Stress Disorder (PTSD)
The National Institute of Mental Health* estimates that 3.6% of American adults struggle with symptoms of Post-Traumatic Stress Disorder (PTSD). This is a mental condition that can occur in victims of violent assault, rape, combat, terrorism, accidents, or natural disasters. PTSD may severely limit the patient’s quality of life due to its symptoms such as anxiety and trauma flashbacks.
Research* shows that the endocannabinoid system plays a crucial role in memory, recall, and emotional regulation. When you consume CBD oil it activates receptors in the ECS. This alters memory, increases pleasure, and reduces the retrieval of traumatic memories associated with PTSD.
6) Sleep Disorders & Insomnia
Sleep matters! A lack of quality or regular sleep can affect your health. Common sleep disorders include excessive daytime sleepiness, sleep apnea, REM sleep behavior disorder, and insomnia. The latter affects approximately 30% of Americans according to the Sleep Association*.
CBD has been shown to improve the quality of sleep by interacting with receptors in the ECS. CBD oil does not, in and of itself, cause sleep. But studies* demonstrate that CBD has the potential to combat insomnia through helping the symptoms that cause the difficulty to sleep, i.e., anxiety, depression, chronic pain, etc. A study* in The Permanente Journal concluded that CBD improved the sleep patterns among 66% of the respondents.
Did you know that 80% of Americans are burdened by stress according to a Gallop Poll*? People are exposed to stressful situations such as tragic events, monetary challenges, or accidents daily. Just like depression and anxiety, CBD has potent therapeutic properties that help to reduce stress.
The CB1 and CB2 receptors in the brain helps to decrease chronic and traumatic stress. A recent article* in the American Journal of Psychiatry showed that CBD helps lower the level of cortisol (the body’s stress hormone), which reduces stress.
The first person to receive CBD for psychosis (a symptom of various mental disorders, including schizophrenia) was reported in 1995*. This report laid the groundwork for additional studies on CBD’s mood-stabilizing properties.
A 2016 study* concluded that “CBD behaves in preclinical and clinical studies as an atypical antipsychotic, improving psychotic-like symptoms.” In simple terms, this says that CBD oil had a positive impact in this study and worked unique compared to drugs commonly prescribed for mental health conditions.
Another study* performed a double-blind, randomized clinical trial of CBD against a potent antipsychotic for patients with schizophrenia showed that CBD “was safe and led to significant clinical improvement, but also displayed a markedly superior side-effect profile.”
According to the American Psychiatric Association*, addiction is a “complex condition, a brain disease that is manifested by compulsive substance use despite harmful consequence.” It is a disease because it alters brain processes. Addictive drugs such as opioids, nicotine, and alcohol influence areas of the brain associated with pleasure. These cues reinforce drug use and lead to addictive behavior.
CBD helps addicts break free from the chains of dependence through its ability to help reduce cravings, manage the symptoms of withdrawal, and even address some of the reasons for dependence. A study* demonstrated that CBD reduced cravings in patients recovering from addiction and helped to lower their levels of stress. The researchers of a 2019 study* on CBD for heroin addiction state that “CBD holds significant promise for treating individuals with heroin use disorder.”
In a 2013 study*, CBD was shown to loosen dependence on opioids by interfering with “brain reward mechanisms responsible for the expression of the acute reinforcing properties of opioids.” Leading the researchers to conclude that “cannabidiol may be clinically useful in attenuating the rewarding effects of opioids.” A study* appearing in the Addiction Journal showed that tobacco addicts had a success rate 40% higher with CBD in comparison to a placebo.
Physical Health Benefits of CBD
Chronic pain can significantly reduce the quality of life, decrease productivity, and increase healthcare costs. For some people, CBD has become an alternative for more dangerous, habit-forming medications like opioids. For the millions of Americans that suffer from chronic pain, finding relief is a priority. To manage severe pain, many people try a multi-pronged approach, trying pain medications, surgery, and alternative therapies.
Luckily, research shows that CBD can help over 126 million* Americans who are in pain. A January 2019 study* demonstrated that CBD has potential as a useful alternative for chronic pain management. The study showed that CBD helped chronic pain by binding to receptors involved in pain (vanilloid TRPV1). It was also observed that CBD regulates and increases several chemicals flowing through the body that reduce the perception of pain.
Some studies* claim that CBD reduces the sensation of pain by interacting with a3 glycine receptors in the brain and spinal cord. In other words, CBD oil controls how we react to pain. There is a growing list of other studies that recommend CBD as a natural pain relief remedy*.
Inflammation is an immune response by the body to keep it safe from injuries, illnesses, and infections. Unfortunately, this attempt by our body can occur in unnecessary places or go on for too long. This can lead to problems like skin conditions, heart diseases, and more.
CBD may offer a new opportunity for helping support movement and healthy joints. The results of a 2009 study* concluded that CBD suppresses the body’s inflammatory response and symptoms by acting on multiple pathways. Recent research* demonstrates that CBD interacts with the immune system, reducing stress and inflammation. In a study* on cannabinoids, researchers found that CBD and THC lower inflammation. This regulates the immune system’s production of numerous cell types that are involved in the inflammatory response. These cell types include T-helper cells, T-regulatory cells, and cytokines.
Migraine headaches are often debilitating; those suffering from the condition know this all too well. The victims experience headaches that can lead to disturbed vision, vomiting, sensitivity to smells, sounds, and light.
Although research is still going, it’s believed that CBD can help with migraines through the neurotransmitters in the brain. One study* by Italian researchers found that a 200mg dose of CBD reduced pain caused by migraines by up to 55%.
Medical studies* have observed that most people who suffer from migraines have unbalanced levels of neurotransmitters such as serotonin. Consequently, low serotonin levels can lead to persistent dilation of the blood vessels in the brain, which increases the frequency of migraine attacks. Luckily, several CBD focused studies* have shown that CBD can increase serotonin levels and also reduce the dilation of blood vessels. Increasing serotonin levels may moderate the onset of migraine attacks according to some researchers.
Additionally, research has shown that cannabinoids have great potential as pain relievers*. These factors give CBD great potential as a viable alternative to other migraine relief methods.
13) Nausea & Vomiting
Nausea is often described as an unpleasant feeling inside the stomach that can usually be followed by vomiting. Nausea is not a disease itself but rather a symptom. It is non-specific to one disease and can originate from many causes, both external and internal. The body reacts with nausea and vomiting as a defense mechanism.
A study* in the British Journal of Pharmacology claimed that CBD is an anti-emetic for reducing nausea and vomiting problems in both adults and children. Another study* showed that there is a link between the area of your brain that controls nausea and the ECS.
A 2019 study concluded based on the evidence from numerous trials that cannabinoids help appetite stimulation and improvement of nausea. More specifically, research* suggests that CBD oil anti-emetic or anti-nausea effects are caused by activating a set of receptors (somatodendritic 5-HT(1A) autoreceptors) in the brain (specifically the Dorsal Raphe Nucleus).
According to the American Arthritis Foundation*, over 3.7 million Americans are affected by fibromyalgia. The symptoms include severe pain, mood changes, memory problems, and fatigue.
In 2016, a review of CBD research* found evidence that cannabinoids appear to be effective for fibromyalgia. CBD benefits people with fibromyalgia by helping manage the symptoms. A 2016 study* also proved that a lack of endocannabinoids in the brain causes health issues such as irritable bowel syndrome, migraines, and fibromyalgia. Therefore, it makes sense that the use of CBD can restore these neurotransmitters and help with fibromyalgia.
According to the American Arthritis Foundation*, 54 million adults have doctor-diagnosed arthritis. Although CBD has not been approved by the Food & Drug Administration (FDA) for arthritis, the research shows that CBD has medical benefits.
According to a study* published in the Journal of Rheumatolo gy, CBD showed impressive results among arthritis patients. Similarly, another study* claimed that CBD reduces inflammation due to arthritis. Research* shows it was useful and safe for managing osteoarthritis, the most common type of arthritis. In 2016, the Arthritis Foundation* published information from a small human trial that found CBD improved pain and insomnia in participants who had OA, RA, and fibromyalgia.
Another study* used a CBD cream on animals with arthritis. The researchers saw that “the data indicate that topical CBD application has therapeutic potential for relief of arthritis pain and inflammation without side-effects.” This makes CBD oil especially effective because it can be ingested or applied as a topical cream.
16) Sports Injury recovery
Athletes often work out and push their bodies with exercise. With the recent removal of CBD from the list of prohibited substances by the World Anti-Doping Agency* the hemp-extract has experienced a surge in popularity among pro athletes, including Bubba Watson (PGA-Golf), Nate Diaz (MMA), and Derrick Morgan (NFL).
Generally, CBD helps with an athlete’s recovery period by reducing inflammation and pain, improving sleep quality, and increasing the level of concentration. More specifically, studies* show that CBD inhibits the reuptake of adenosine to enhance the quality of sleep. This is crucial because quality sleep improves cognitive performance, and the human body mostly regenerates damaged muscle fiber during sleep. Additionally, research observed that CBD binds to CB2 receptors and reduces inflammation by regulating the production of cytokine.
Over 5 million Americans suffer from acne every year according to the American Academy of Dermatology*. Aside from skin discomfort, an outbreak of acne can lead to social stigma, lower self-esteem, and even depression. Acne is caused by bacteria in skin pores, oil clogs, and dead skin, leading to inflammation. It’s triggered by hormonal changes, puberty, menstruation, emotional stress, and external stimuli (medications and cosmetics).
CBD oil has also been proven to have effects that provide significant relief against mild flare-ups of acne. In particular, a study* demonstrated that CBD’s anti-inflammatory effects provide promising results for acne patients.
A study* published in The Journal of Clinical Investigation shows that CBD helps relieve the symptoms of acne by reducing inflammation and lowering the production of sebum, a skin lubricating oil. CBD may also help in regulating risk factors of acne, such as hormonal changes and emotional distress.
The National Eczema Association* estimates that there are over 30 million Americans affected by Eczema. The skin condition is seen as inflamed, red, and itchy skin. Fortunately, it is manageable through the use of CBD topicals and antihistamines. The results of a study* published in the Journal of American Academy of Dermatology claimed that CBD might help with a wide range of skin conditions including psoriasis, eczema, itching, allergies, and dandruff.
The ECS plays a crucial role in skin functions. According to this study*, CBD interacts with CB1 receptors and keratinocytes. This helps to maintain the permeability barrier, epidermal integrity, and protect the skin from allergic inflammation.
The human body typically makes new skin cells in weeks. However, 7.5 million Americans suffer from a skin condition known as psoriasis. Psoriasis cuts skin regeneration period to days, according to the American Academy of Dermatology*. This results in thick and scaly patches on the skin due to a pile-up of skin cells. Although the causes of the skin condition are not known, some sources* claim that the immune system (T-cells attacking skin cells) and genetics play a key part.
Using CBD might help the immune system and prevent white blood cells from attacking healthy skin cells. According to a study* appearing in the Journal of Dermatological Science, CBD may help by inhibiting the proliferation of keratinocytes involved in making new skin cells.
20) Multiple Sclerosis
Multiple sclerosis is an autoimmune condition. Unfortunately, there are more than 2.3 million people in the world diagnosed with multiple sclerosis. 200 cases are reported every week in the United States according to the MS Discovery Forum*.
CBD oil is now seen as a potential remedy due to its ability to alleviate some symptoms of multiple sclerosis, such as pain and spasticity. A study published in the Journal of Neuropharmacology showed that CBD binds to CB1 rectors, causing effects that help manage multiple sclerosis. Additionally, a study* concluded that CBD “is effective in reducing pain and sleep disturbance in patients with multiple sclerosis-related pain and is mostly well tolerated.”
According to the Foundation for Peripheral Neuropathy*, peripheral neuropathy occurs when nerves are destroyed or damaged, hindering their ability to send messages from the central nervous system (brain and spinal cord) to other parts of the body. Neuropathy affects over 20 million Americans who describe the nerve pain as a stabbing, burning, tingling, or a numbing sensation.
A growing body of studies suggests that CBD is promising for many forms of neuropathic pain. In particular, Researchers* believe CBD helps by modulating brain and endocrine activities, regulating vanilloid TRPV1 pain receptors, controlling the absorption of anandamide, and targeting a3 glycine receptors. CBD also helps to improve the quality of sleep and the patient’s general well-being.
22) Back pain
Back pain is a health issue that affects most of us at one time in our lives. Whether acute or chronic, back pain can be disabling. Treatment for lower back pain often involves a complex regimen of lifestyle changes, physical therapy, and even surgery, in extreme cases. Patients are increasingly using CBD oil and CBD topicals to help alleviate the symptoms of lower back pain.
Scientific studies indicate that CBD oil benefits back pain. In early 2018, the Journal of Pain Research* published a study about chronic pain in patients who didn’t respond to back surgery. Researchers found that both CBD and THC significantly helped to reduce pain in the study participants. Also, a study* using animal test subjects demonstrated that CBD reduced the severity of injury damage and the effects caused by disc degeneration in the vertebrae.
24) Obesity & Weight Loss
Did you know that nearly 4 in every 10 Americans is obese? Obesity has a negative impact on the health, economic, social status of an individual according to the CDC*. Research* shows that the ECS and CBD help with obesity by promoting sugar metabolism, insulin production, and converting fat tissue into caloric expenditure. The ECS is known to regulate energy expenditure, food intake, and metabolic processes. As a result, a survey* in the American Journal of Epidemiology showed obesity rates were ~33% lower among CBD users.
25) Gastrointestinal & Digestive
In the United States, the National Institute of Diabetes, Digestive, and Kidney Diseases* estimate that more than 60 million Americans suffer from a stomach issue. Although GI issues are relatively common, studies* show that they can have effects that severely impact quality of life.
With such a crucial role in our body, promoting digestive health is a necessity. A study* in the Journal of Cannabis and Cannabinoid Research claimed that the ECS plays a vital role in digestive health. In particular, the ECS helps with immune response, gut motility, hunger, interaction with microbiota, gut permeability, and brain-mediated fat intake. Recent research* also demonstrates that CBD might be able to help regulate bowel movements and improve the overall well-being.
26) Irritable Bowel Syndrome (IBS)
The symptoms of Irritable Bowel Syndrome can range from a build-up of gas in the stomach to severe abdominal pain. Other symptoms include constipation, diarrhea, and cramping. Although IBS does not have a cure, it is possible to manage the symptoms with the help of CBD.
A study* in the Journal of Phytotherapy Research proved that the anti-inflammatory and immunomodulatory properties of CBD could help alleviate the symptoms of Irritable Bowel Syndrome. Other studies* suggest that a deficiency of endocannabinoids in the digestive tract is directly linked to IBS symptoms. Therefore, the intake of CBD could help regulate the ECS and restore proper function.
27) Brain Health
In recent decades, there has been significant progress in understanding the human brain. But, there are still gaps in the knowledge of the mechanisms of brain functioning. CBD is of interest when studying brain health due to its influences on neurological functions and lack of side effects.
Various studies* have observed the benefits of CBD on a long list of brain pathways. CBD’s benefits for brain health are attributed to the removal of damaged cells, improving the efficiency of mitochondria, preserving cerebral circulation during ischemic events, reducing toxicity, and maintaining stasis of nerve cell stimuli.
In one study*, researchers found that CBD helps to enhance the brain’s neuroplasticity and neurogenesis, and promotes healthy brain cells. Another study* also showed that due to the powerful anti-oxidant effect of CBD, it could reduce stress in the brain. This oxidative stress contributes to the cognitive decline associated with the normal aging process.
According to a 2017 study on the neurological aspects of medical use of CBD, Pre-clinical evidence* largely shows that CBD can produce beneficial effects in Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis patients, but its use needs further confirmation.
In 2016, researchers at the University of Miami began a five-year study* to examine the effects of CBD on sports-related concussions. Researchers hypothesized that CBD could be combined with an anesthetic to reduce the symptoms of concussions. The findings of the pre-clinical testing were strong enough to move into the next phase of human testing. Additional research, such as the University of Miami study, is still needed to fully understand how CBD helps specific neurological and degenerative brain diseases.
28) Drug Withdrawal
Overcoming drug and opioid addiction is easier said than done. This is mainly due to the life-threatening withdrawal symptoms. But similar to its other effects on addiction, CBD is being used as a possible remedy to help drug addicts overcome withdrawal.
A 2018 study* shows that CBD may help in reducing some of the withdrawal symptoms of alcohol addiction, such as insomnia, anxiety, and nausea. This study also revealed that CBD helps reduce the addiction-motivation to take alcohol, prevent relapse, and reduce alcohol intake.
A study* in the Journal of Neurotherapeutics concluded that “CBD could…indirectly regulate neural systems modulating opioid-related behavior, thus helping in regulating neural systems modulating opioid-related behavior.” The authors also claimed that CBD helps reduce pain, insomnia, mood disorders, and anxiety as symptoms of addiction.
29) BONE HEALTH
CBD has been shown through many studies to help with long-term bone health. A scientific review* found that the ECS plays a crucial role in the regulation of bone metabolism, controlling everything from how much fat is being stored within the bones, how many new bone cells are produced, and the rate at which older bone cells are being broken down.
A study published in 2009* found that endocannabinoid receptors help to slow down the bone decay that happens throughout the normal aging process. Based on this evidence, CBD has been cited as an option for preventing common bone injuries and other common bone diseases from aging.
30) Cardiovascular health
Cardiovascular diseases, such as strokes and heart attacks, are the leading cause of death. According to the World Health Organization*, nearly 18 million people die annually due to cardiovascular health issues. In addition to dietary changes, exercise, and other lifestyle changes, CBD oil is viewed as a natural and safe therapeutic compound.
A study published in 2017* demonstrated that CBD could efficiently reduce blood pressure. This study also showed that CBD could alter the way the body responds to stress. Stress is a factor that can often cause elevated blood pressure and is a major contributor to heart disease and heart attack. By taking CBD oil, we could maintain healthy blood pressure and reduce the risk of heart disease and heart attacks.
A systematic review* in the British Journal of Clinical Pharmacology claimed that the anti-oxidant and anti-inflammatory properties of CBD might help in reducing negative responses to a different model of stress, promote relaxation, and work on isolated arteries. The researchers concluded that “taken together, these preclinical data appear to support a positive role for CBD treatment in the heart, and in the peripheral and cerebral vasculature.”
Research* has also identified that CBD could be beneficial in blood flow, vasorelaxation, the survival and death of the white blood cells, and the flow of white blood cells throughout the body. Although more research is required to fully understand how CBD can play a role in heart health, these studies show the positive implications that using CBD could have on cardiovascular health.
Unproven Benefits of CBD
There are many other effects that people are claiming about CBD. Unfortunately, there is not enough evidence at this time to support these claims. If you are curious about these effects and use of CBD, we will list them here and update them as more research is published. Please note that there is not enough information to support the following claims:
Side effects of CBD
Many people believe that there is almost no downside to taking CBD. The World Health Organization* states that CBD is safe and non-toxic. Also, it is non-addictive, doesn’t get the user high, and has minimal side effects. There are no withdrawal symptoms when users stop taking CBD. Also, CBD oil has zero overdoses. In clinical safety trials*, the human body tolerates doses up to 1500mg (60x the common daily usage).
Although rare, some individuals report minor CBD side effects. These side effects included: changes in appetite, mood, anxiety, diarrhea, dizziness, drowsiness, nausea, and fatigue. Clinical trials* have demonstrated that the side effects of CBD oil are fewer and less severe than some prescription drug alternatives.
Final thoughts on the benefits of CBD
People from all walks of life are crediting CBD with a variety of health and wellness benefits. Research is still ongoing for the potential health benefits of CBD. However, the results from thousands of CBD studies on humans and animals are promising. As more studies are published and more data is available, we will be able to evaluate the uses of CBD better. Yet, it is reasonable to say that based on the evidence that CBD is not a fad, not snake oil, and it isn’t a trend that will fade quickly. CBD has the potential to make a significant impact on the health and quality of life for millions of people in the future.
Evidence for using CBD
There is a long list of studies on the benefits of CBD. As of January 2019, there are over 10,000 published studies or reviews related to CBD in the U.S. National Library of Medicine’s PubMed Central Database*. More than half of these have been published in the last five years. Evidence for CBD’s effectiveness comes from these types of studies:
- Exploratory Medical Research – Observations in a lab, including cell studies, biological and biochemical testing, and imaging.
- Pre-Clinical Research – Research that studies animals to identify if a treatment will be effective for human subjects.
- Clinical Research – Studies using humans to identify if a new treatment is effective for a medical condition. There are multiple steps to clinical studies. The early phase of research focuses on small clinical trials with healthy subjects to see side effects and safety. The next phase focuses on larger groups of patients, typically comparing against a placebo or equal treatment.
The recent popularity of CBD has resulted in more research than many pharmaceutical medicines that have been approved by the US Food and Drug Administration (FDA). There are 10,000 studies on CBD, but an analysis of the FDA’s approval of new prescription drugs* from 2005-2012 showed that 36.8% of new treatments were approved after only a single clinical trial.
How to take CBD
The variety of options for taking CBD can be confusing. To help figure out the best way for you, we’ve created this guide. This will cover the topics that are valuable for new and experienced CBD users.
POPULAR TYPES OF CBD PRODUCTS
- Oil or sublingual
- Cream or lotion
- premade edibles
- pill or capsule
- pet products
Does CBD make you high?
CBD does not have any intoxicating properties. Instead, it is the answer for people looking for health and wellness benefits without the feeling of being high. THC (tetrahydrocannabinol) is the primary psychoactive chemical that makes people feel high.
Is CBD (Cannabidiol) legal?
The legal status of CBD depends on if the chemical came from hemp or a cannabis plant with a higher THC content.
- If the CBD comes from hemp (less than 0.3% THC), then YES, it is federally legal to use and own anywhere in the United States.
- If the CBD comes from a cannabis plant with a high (more than 0.3%) THC content, then it is considered a controlled substance. This means that products from high THC plants (marijuana) are illegal on the federal level. Some states may have specific regulations for recreational or medicinal marijuana use.
That is the quick answer. Owning, using, and buying CBD online is 100% LEGAL anywhere in the United States if the product is made from hemp. All Daddy Burt Hemp Co. CBD products are made from hemp. If you still have other legal questions about CBD, this article simplifies the confusing legal status of CBD by answering the popular questions. We are not lawyers, so we are not giving legal advice. Instead, we are gathering information from across the country so that people can make sense of their legal questions.
Note: The information on our website and any other communication of Daddy Burt Hemp Co. is for informational purposes only and is not intended as legal advice.
Benefits of CBD
Based on the evidence explained above, it makes sense why people are using CBD for a wide range of wellness reasons. Some people are even using CBD for their pets!
Are you or a loved one interested in the effectiveness of these benefits of CBD? If so, you can read more detailed information about how CBD can potentially help a health condition by clicking the links below.
ADD & ADHDAddictionAnxietyArthritisAutismBack PainDepressionFibromyalgiaGastrointestinalMigrainesInflammationPainPeripheral NeuropathyPreventative HealthPsoriasisSkin HealthSleepWeight ManagementCBD For Pets – DogsCBD For Pets – Cats
Note: If you are considering CBD products, talk to your doctor to see if it is a good fit for you. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
*About Psoriasis. (2018, October). National Psoriasis Foundation. Webpage.
*Acne. American Academy of Dermatology. Webpage.
*Alen, F., Ramirez-Lopez, T., Gomez, R., Rodriguez, F., & Orio, L. (2017, April). Cannabinoid Receptors and Cholecystokinin in Feeding Inhibition.
*Alger, B. E. (2013, November). Getting high on the endocannabinoid system.
*Alvarez, F. J., Lafuente, H., Rey-Santano, M. C., Mielgo, V. E., Gastiasoro, E., Rueda, M., … & Martinez-Orgado, J. (2008). Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets. Pediatric research, 64(6), 653.
*Aran, A. (2018, July). Study: Cannabis oil 80% successful in helping autistic children.
*Arditi, L. (2018, December). After Other Options Fail, A Family Tries Medical Marijuana For Son With Autism.
*Autism Spectrum Disorders. (2018, April). World Health Organization. Webpage.
*Bab, I., & Zimmer, A. (2008). Cannabinoid receptors and the regulation of bone mass.
*Bab, I., Zimmer, A., & Melamed, E. (2009). Cannabinoids and the skeleton: From marijuana to reversal of bone loss.
*Barnes, M. P. (2006, April). Sativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain.
*Baron, E. P. (2018, August 27). Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science.
*Bátkai, S., Járai, Z., Wagner, J. A., Goparaju, S. K., Varga, K., Liu, J., … Kunos, G. (2001, July). Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis.
*Bergamaschi, M. (2011, May). Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients.
*Bisson, R. (2018, August). Cannabis extract helps reset brain function in psychosis. King’s College London.
*Bitencourt, R. M., & Takahashi, R. N. (2018). Cannabidiol as a therapeutic alternative for post-traumatic stress disorder: From bench research to confirmation in human trials. Frontiers in neuroscience, 12.
*Blake, D. R., Robson, P., Ho, M., Jubb, R. W., & McCabe, C. S. (2006). Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology, 45(1), 50-52.
*Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015, October). Cannabidiol as a Potential Treatment for Anxiety Disorders.
*Booz, G. W. (2011). Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. Free Radical Biology and Medicine, 51(5), 1054-1061.
*Brigida, A. L., Schultz, S., Cascone, M., Antonucci, N., & Siniscalco, D. (2017, July). Endocannabinoid Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations.
*Burstein, S. (2015, April 01). Cannabidiol (CBD) and its analogs: A review of their effects on inflammation.
*CANNABIDIOL (CBD) Report. (2017, November). Expert Committee on Drug Dependence. World Health Organization.
*Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial. (2017, May 30).
*Cassuto, H., Lubotzky, A., & Aran. (2018, April 10). Cannabidiol Based Medical Cannabis in Children with Autism- a Retrospective Feasibility Study.
*CBD. (2019). PMC – US National Library of Medicine National Institutes of Health.
*Centers For Disease Control and Prevention. National Health Report Highlights.
*Chelliah, M. (2018, May). Self‐Initiated Use of Topical Cannabidiol Oil for Epidermolysis Bullosa.
*Chronic Pain: Definition & Management – When Seconds Count. American Society of Anesthesiologists. Webpage.
*Concussion Pill’ Shows Promise in Pre-Clinical Pilot Study. (2018, July). University of Miami Miller School of Medicine.
*Cooper, R. E., Williams, E., Seegobin, S., Tye, C., Kuntsi, J., & Asherson, P. (2017). Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial. European Neuropsychopharmacology, 27(8), 795-808.
*Corroon, J., & Phillips, J. A. (2018, July 01). A Cross-Sectional Study of Cannabidiol Users.
*Crawford, M. R., Chirinos, D. A., Iurcotta, T., Edinger, J. D., Wyatt, J. K., Manber, R., & Ong, J. C. (2017, July 15). Characterization of Patients Who Present With Insomnia: Is There Room for a Symptom Cluster-Based Approach?
*Crippa, J. A., Derenusson, G. N., Ferrari, T. B., Wichert-Ana, L., Duran, F. L., Martin-Santos, R., … Hallak, J. E. (2011, January). Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: A preliminary report.
*Darkovska-Serafimovska, M., Serafimovska, T., Arsova-Sarafinovska, Z., Stefanoski, S., Keskovski, Z., & Balkanov, T. (2018, April). Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases.
*Data & Statistics on Autism Spectrum Disorder. (2019). Centers for Disease Control and Prevention. Webpage.
*De Gregorio, D., McLaughlin, R. J., Posa, L., Ochoa-Sanchez, R., Enns, J., Lopez-Canul, M., … & Gobbi, G. (2019). Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain. Pain, 160(1), 136.
*Depression Facts & Statistics. Anxiety and Depression Association of America. Webpage.
*Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., … & Wright, S. (2017). Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. New England Journal of Medicine, 376(21), 2011-2020.
*Devinsky, O., Whalley, B. J., & Marzo, V. D. (2015). Cannabinoids in the Treatment of Neurological Disorders.
*Di Marzo, V. (2008, August). The endocannabinoid system in obesity and type 2 diabetes.
*Diagnostic and Statistical Manual of Mental Disorders: DSM-5. (2019). American Psychiatric Association.
*Digestive Diseases Statistics for the United States. (2014, November). National Institute of Diabetes and Digestive and Kidney Diseases. Webpage.
*Digestive diseases. (2019). MedlinePlus Medical Encyclopedia. Webpage.
*DiPatrizio, N. V. (2016). Endocannabinoids in the Gut. Cannabis and cannabinoid research, 1(1), 67-77.
*Dobrosi, N., Toth, B., Nagy, G., Dozsa, A., … Biro, T. (2008, July). Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling.
*Downing, N. (2014, January). Trial Evidence and FDA Approval of Novel Agents.
*Drunk driving statistics. (2018, January). Webpage.
*Dual Diagnosis of Down Syndrome and Autism (2019). National Down Syndrome Society. Webpage.
*Early Identification of Autism. (2018, May). American Academy of Pediatrics. Webpage.
*Esposito, G., Filippis, D. D., Cirillo, C., Iuvone, T., Capoccia, E., Scuderi, C., … Steardo, L. (2012, July). Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview.
*Expert Committee on Drug Dependence. Cannabidiol (CBD) Critical Report. (2018, June). World Health Organization.
*Farrell, M. (1994, November). Opiate withdrawal.
*Farrimond, J. A., Whalley, B. J., & Williams, C. M. (2012, September). Cannabinol and cannabidiol exert opposing effects on rat feeding patterns.
*Fitzcharles, M., Baerwald, C., Ablin, J., & Häuser, W. (2016, February). Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): A systematic review of randomized controlled trials.
*Galvin, B. (2017, March). Four-year old Georgia boy ‘different child’ on cannabis oil.
*Gates, P. J., Albertella, L., & Copeland, J. (2014, December). The effects of cannabinoid administration on sleep: A systematic review of human studies.
*Genaro, K., Fabris, D., Arantes, A. L., Zuardi, A. W., Crippa, J. A., & Prado, W. A. (2017). Cannabidiol is a potential therapeutic for the affective-motivational dimension of incision pain in rats. Frontiers in Pharmacology, 8, 391.
*GI Disorders Functional GI Disorders Motility Disorders Upper GI Disorders Lower GI Disorders Other Disorders Kids & Teens. (2015, September). International Foundation for Gastrointestinal Disorders. Webpage.
*Gillman, A. S., Hutchison, K. E., & Bryan, A. D. (2015, July). Cannabis and Exercise Science: A Commentary on Existing Studies and Suggestions for Future Directions.
*Gonzalez-Cuevas, G., Martin-Fardon, R., Kerr, T. M., Stouffer, D. G., Parsons, L. H., Hammell, D. C., … Weiss, F. (2018, September). Unique treatment potential of cannabidiol for the prevention of relapse to drug use: Preclinical proof of principle.
*Gramlich, J., & Gramlich, J. (2018, May). Many in US say drug addiction is a major problem in their community. Webpage.
*Granowicz, J. (2016, March). The Endocannabinoid System: A History of Endocannabinoids and Cannabis. Webpage.
*Greco, R., Gasperi, V., Maccarrone, M., & Tassorelli, C. (2010, July). The endocannabinoid system and migraine.
*Gregorio, D. D., McLaughlin, R., Posa, L., Ochoa-Sanchez, R., Enns, J., Lopez-Canul, M., … Gobbi, G. (2019, January 01). Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain.
*Grinspoon, P. (2018, August 24). Cannabidiol (CBD) – what we know and what we don’t.
*Gruden, G., Barutta, F., Kunos, G., & Pacher, P. (2016, April). Role of the endocannabinoid system in diabetes and diabetic complications.
*Habib, S. S., Al-Regaiey, K., Bashir, S., & Iqbal, M. (2017, June). Role of Endocannabinoids on Neuroinflammation in Autism Spectrum Disorder Prevention.
*Hammell, D. C., Zhang, L. P., Ma, F., Abshire, S. M., McIlwrath, S. L., Stinchcomb, A. L., & Westlund, K. N. (2016, July). Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis.
*Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998, July 07). Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
*Headache disorders. World Health Organization. Webpage.
*Headaches. (2019). John Hopkins Medicine. Webpage.
*Hindocha, C., Freeman, T. P., Grabski, M., Stroud, J. B., Crudgington, H., Davies, A. C., … Curran, H. V. (2018, June). Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal.
*Hurd, Y. (2012, May). Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent Humans – Full Text View.
*Hurd, Y. L., Spriggs, S., Alishayev, J., Winkel, G., Gurgov, K., Kudrich, C., . . . Salsitz, E. (2019, May). Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial.
*Hurd, Y. L., Yoon, M., Manini, A. F., Hernandez, S., Olmedo, R., Ostman, M., & Jutras-Aswad, D. (2015). Early phase in the development of cannabidiol as a treatment for addiction: opioid relapse takes initial center stage. Neurotherapeutics, 12(4), 807-815.
*Iffland, K., & Grotenhermen, F. (2017, June 01). An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies.
*Izzo, A., & Coutts, A. (2005). Cannabinoids and the digestive tract.
*Jadoon, K. A., Tan, G. D., & O’Sullivan, S. E. (2017). A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study.
*Járai Z., Wagner J.A., Varga K., Lake K.D., Compton D.R., Martin B.R., Zimmer A.M., Bonner T.I., Buckley N.E., Mezey E., Razdan R.K., Zimmer A., Kunos G. (1999). Cannabinoid-induced mesentric vasodilation through an endothelial site distinct from CB1 and CB2 receptors. Proceedings of the National Academy of Sciences of the United States of America
*Kaplan, B. L., Springs, A. E., & Kaminski, N. E. (2008, September). The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT).
*Kaplan, B. L., Springs, A. E., & Kaminski, N. E. (2008). The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT). Biochemical pharmacology, 76(6), 726-737.
*Katsidoni, V., Anagnostou, I., & Panagis, G. (2013, March). Cannabidiol inhibits the reward-facilitating effect of morphine: Involvement of 5-HT1A receptors in the dorsal raphe nucleus.
*Keeping Your Gut in Check. (2017, October). News In Health. Webpage.
*Khan, M., Sobocinska, A., Czarnecka, A., Krol, M., Botta, B., & Szczylik,C. (2016, March). The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.
*Kirkham, T. C. (2009, April). Cannabinoids and appetite: Food craving and food pleasure.
*Klotz, K. A., Schulze-Bonhage, A., Antonio-Arce, V. S., & Jacobs, J. (2018, September 07). Cannabidiol for Treatment of Childhood Epilepsy-A Cross-Sectional Survey.
*Kogan, N. M., Melamed, E., Wasserman, E., Raphael, B., Breuer, A., Stok, K. S., … & Friedlander‐Barenboim, S. (2015). Cannabidiol, a Major Non‐Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts. Journal of Bone and Mineral Research, 30(10), 1905-1913.
*Komorowski, J., & Stepień, H. (2007). The role of the endocannabinoid system in the regulation of endocrine function and in the control of energy balance in humans.
*Kunos, G., Osei-Hyiaman, D., Liu, J., Godlewski, G., & Bátkai, S. (2008, November). Endocannabinoids and the control of energy homeostasis.
*Le Foll, B., Trigo, J., Sharkey, K., & Strat, Y. (2013, February 11). Cannabis and Δ9-tetrahydrocannabinol (THC) for weight loss.
*Le Strat, Y., & Le Foll, B. (2011). Obesity and cannabis use: results from 2 representative national surveys. American journal of epidemiology, 174(8), 929-933.
*Leweke, F. (2012, March). Cannabidiol Enhances Anandamide Signaling and Alleviates Psychotic Symptoms of Schizophrenia.
*Li, H., Kong, W., Chambers, C. R., Yu, D., Ganea, D., Tuma, R. F., & Ward, S. J. (2018, July). The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice.
*Linge, R., Jiménez-Sánchez, L., Campa, L., Pilar-Cuéllar, F., Vidal, R., Pazos, A., … & Díaz, Á. (2016). Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors. Neuropharmacology, 103, 16-26.
*Lio, P., Yardley, H., & Fernandez, J. (2018). Can marijuana help eczema?
*Liput, D. J., Hammell, D. C., Stinchcomb, A. L., & Nixon, K. (2013, October). Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder.
*Lochte, B. C., Beletsky, A., Samuel, N. K., & Grant, I. (2017, April 01). The Use of Cannabis for Headache Disorders.
*Lu, H., & Mackie, K. (2016, April). An Introduction to the Endogenous Cannabinoid System.
*Lucas, P. (2012). Cannnabis as an adjunct to or substitute for opiates in the treatment of chronic pain.
*Mannucci, C. (2017). Neurological Aspects of Medical Use of Cannabidiol.
*Marco, E., Rapino, C., Caprioli, A., Borsini, F., Maccarrone, M., & Laviola, G. (2011, February). Social encounter with a novel partner in adolescent rats: Activation of the central endocannabinoid system.
*Maroon, J., & Bost, J. (2018, April). Review of the Neurological Benefits of Phytocannabinoids.
*McCormick, J. B., Hammer, R. R., Farrell, R. M., Geller, G., James, K. M., Loftus, E. V., … Sharp, R. R. (2012, March). Experiences of patients with chronic gastrointestinal conditions: In their own words.
*McDonough, P., McKenna, J. P., McCreary, C., & Downer, E. J. (2014, October). Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue.
*Merica, D. (2017, October). Trump declares opioid epidemic a public health emergency. Webpage.
*Mondello, E., Quattrone, D., Cardia, L., Bova, G., Mallamace, R., Barbagallo, … Calapai, G. (2018, September 06). Cannabinoids and spinal cord stimulation for the treatment of failed back surgery syndrome refractory pain.
*Morgan, C. J., Das, R. K., Joye, A., Curran, H. V., & Kamboj, S. K. (2013, September). Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings.
*Mori, M. A., Meyer, E., Soares, L. M., Milani, H., Guimarães, F. S., & Oliveira, R. M. (2017). Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia.
*Morin, M., C., Hauri, J., P., Espie, Spielman, … R., R. (1999, December 01). Nonpharmacologic Treatment of Chronic Insomnia.
*Mouhamed, Y., Vishnyakov, A., Qorri, B., Sambi, M., Frank, S. S., Nowierski, C., … Szewczuk, M. R. (2018, June 11). Therapeutic potential of medicinal marijuana: An educational primer for health care professionals.
*Mounessa, J., Siegel, J., Dunnick, C., & Dellavalle, R. (2017, July). The role of cannabinoids in dermatology.
*Murillo-Rodriguez, E., Blanco-Centurion, C., Sanchez, C., Piomelli, D., & Shiromani, P. (2003, December). Anandamide Enhances Extracellular Levels of Adenosine and Induces Sleep: An In Vivo Microdialysis Study.
*Musich, S., Wang, S., Hawkins, K., & Klemes, A. (2016). The Impact of Personalized Preventive Care on Health Care Quality, Utilization, and Expenditures.
*Nagarkatti, P., Pandey, R., Rieder, S. A., Hegde, V. L., & Nagarkatti, M. (2009, October). Cannabinoids as novel anti-inflammatory drugs.
*National Institute on Drug Abuse. (2015, June). The Biology and Potential Therapeutic Effects of Cannabidiol.
*National Institute on Drug Abuse. (2018, January). Is nicotine addictive? Webpage.
*National Institute on Drug Abuse. (2018, June). Heroin. Webpage
*National Institute on Drug Abuse. (2019, January). Overdose Death Rates. Webpage.
*Nijs, J., Loggia, M. L., Polli, A., Moens, M., Huysmans, E., Goudman, L., … Clauw, D. (2017, August). Sleep disturbances and severe stress as glial activators: Key targets for treating central sensitization in chronic pain patients?
*Office of Dietary Supplements (2019). Dietary Supplements for Weight Loss. Webpage.
*Office of the Commissioner. (2018, June). Press Announcements – FDA Approves First Drug Comprised of an Active Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy.
*Oláh, A., Tóth, B. I., Borbíró, I., Sugawara, K., Szöllõsi, A. G., Czifra, G., … Bíró, T. (2014, September). Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.
*Opioid Overdose. (2017, August). Centers For Disease Control and Prevention. Webpage.
*Pacher, P., Bátkai, S., & Kunos, G. (2006, September). The endocannabinoid system as an emerging target of pharmacotherapy.
*Pain Medicine Journal. American Academy of Pain Medicine. Webpage.
*Parekh, R. (2017, January). What is Addiction? American Psychiatry Association. Webpage.
*Parker, L. A., Burton, P., Sorge, R. E., Yakiwchuk, C., & Mechoulam, R. (2004, September). Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
*Parker, L. A., Rock, E. M., & Limebeer, C. L. (2011). Regulation of nausea and vomiting by cannabinoids. British journal of pharmacology, 163(7), 1411-1422.
*Parray, H. A., & Yun, J. W. (2016, May). Cannabidiol promotes browning in 3T3-L1 adipocytes.
*Patel, S., Hill, M. N., Cheer, J. F., Wotjak, C. T., & Holmes, A. (2017). The endocannabinoid system as a target for novel anxiolytic drugs. Neuroscience & Biobehavioral Reviews, 76, 56-66.
*Pava, M. J., Makriyannis, A., & Lovinger, D. M. (2016). Endocannabinoid signaling regulates sleep stability. PLoS One, 11(3), e0152473.
*Peripheral Neuropathy Fact Sheet. (2019). National Institute of Neurological Disorders and Stroke. Webpage.
*Pertwee, R. G. (2006, January). Cannabinoid pharmacology: The first 66 years.
*Philpott, H. T., O’brien, M., & McDougall, J. J. (2017). Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. Pain, 158(12), 2442.
*Piermarini, C., & Viswanath, O. (2019). CBD as the New Medicine in the Pain Provider’s Armamentarium. Pain and therapy, 8(1), 157-158.
*Piomelli, D., Weiss, S., Boyd, G., Pacula, R. L., & Cooper, Z. (2018, April 01). Cannabis and the Opioid Crisis.
*Qorri, B., Szewczuk, M., Kalaydina, R. (2017, October). Preventing Negative Shifts in Gut Microbiota with Cannabis Therapy.
*Rahn, E. J., & Hohmann, A. G. (2009, October). Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside.
*Rath, L. (n.d.). CBD Oil: Should You Try It for Arthritis Symptoms? Webpage.
*Reiman, A., Welty, M., & Soloman, P. (2017, June). Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report.
*Research on Autism Spectrum Disorder. (2019). Centers for Disease Control and Prevention. Webpage.
*Rhyne, D. N., Anderson, S. L., Gedde, M., & Borgelt, L. M. (2016, May). Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population.
*Richardson father risks freedom to promote cannabis treatments for his daughter. (2017, February).WFAA.
*Riddle, D. R., (2007). Brain aging: Models, methods, and mechanisms.
*Rodríguez de Fonseca, F., Del Arco, I., Bermudez-Silva, F. J., Bilbao, A., Cippitelli, A., & Navarro, M. (2005). The endocannabinoid system: Physiology and pharmacology.
*Rog, D. J., Nurmikko, T. J., Friede, T., & Young, C. A. (2005). Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology, 65(6), 812-819.
*Rohleder, C. (2016, November). Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence.
*Rosenson, R. S. (2009). Role of the endocannabinoid system in abdominal obesity and the implications for cardiovascular risk.
*Rossi, F., Punzo, F., Umano, G. R., Argenziano, M., & Miraglia Del Giudice, E. (2018, September 10). Role of Cannabinoids in Obesity.
*Russo, E. B. (2008, February). Cannabinoids in the management of difficult to treat pain.
*Russo, E. B. (2008). Cannabinoids in the management of difficult to treat pain. Therapeutics and clinical risk management, 4(1), 245.
*Russo, E. B. (2016, July 01). Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes.
*Sales, A. J., Fogaça, M. V., Sartim, A. G., Pereira, V. S., Wegener, G., Guimarães, F. S., & Joca, S. R. (2019, February). Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex.
*Sales, A., Crestani, C., Guimarães, F., & Joca, S. (2018, June 06). Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels.
*Schier, Mello, A. R., Ribeiro, Oliveira, N. P., Silva, Oliveira, A. C., … Waldo, A. (n.d.). Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug.
*Schleider, L. B., Mechoulam, R., Saban, N., Meiri, G., & Novack, V. (2019, January). Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy.
*Schuelert, N., & McDougall, J. J. (2011, August 01). The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55.
*Schwartz, Y. (2017, April). Marijuana may be a miracle treatment for children with autism.
*Scotter, E. L., Abood, M. E., & Glass, M. (2010, June). The endocannabinoid system as a target for the treatment of neurodegenerative disease.
*Shannon, S., & Opila-Lehman, J. (2016). Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report.
*Shannon, S., Lewis, N., Lee, H., & Hughes, S. (2019). Cannabidiol in anxiety and sleep: a large case series. The Permanente journal, 23.
*Sharkey, K. A., & Wiley, J. W. (2016). The role of the endocannabinoid system in the brain–gut axis. Gastroenterology, 151(2), 252-266.
*Silveira, J. W., Issy, A. C., Castania, V. A., Salmon, C. E. G., Nogueira-Barbosa, M. H., Guimarães, F. S., … Bel, E. D. (2014). Protective Effects of CBD on Lesion-Induced Intervertebral Disc Degeneration. PLoS ONE, 9(12).
*Siniscalco, D., Sapone, A., Giordano, C., Cirillo, A., Magistris, L. D., Rossi, F., … Antonucci, N. (2013, April). Cannabinoid Receptor Type 2, but not Type 1, is Up-Regulated in Peripheral Blood Mononuclear Cells of Children Affected by Autistic Disorders.
*Sleep Disorders. National Sleep Foundation. Webpage.
*Sources of Arthritis Pain. Arthritis Foundation. Webpage.
*Stanley, C. P., Hind, W. H., & Osullivan, S. E. (2013). Is the cardiovascular system a therapeutic target for cannabidiol?
*Tabassum, N., & Hamdani, M. (2014). Plants used to treat skin diseases.
*Taylor, L., Gidal, B., Blakely, B., Tayo, B., & Morrison, G., (2018). A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability, and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
*The Prohibited List. (2019, January 01). World Anti-Doping Agency. Webpage.
*Thompson, E. (2018, June). The Endocannabinoid System, Our Universal Regulator.
*Tringale, R., & Jensen, C., (2011, August). Cannabis and Insomnia.
*Tüting, T., & Gaffal, E. (2017). Regulatory Role of Cannabinoids for Skin Barrier Functions and Cutaneous Inflammation. In Handbook of Cannabis and Related Pathologies (pp. 543-549). Academic Press.
*U.S. National Library of Medicine. (2018, April). Sativex for Relieving Persistent Pain in Patients with Advanced Cancer (SPRAY III)
*University of Wisconsin Hospitals and Clinics Authority. (2017). Understanding the Basics of Skin Care. Webpage.
*Ward, S. (2014, February). Cannabidiol Inhibits Paclitaxel-Induced Neuropathic Pain through 5-HT(1A) Receptors without Diminishing Nervous System Function or Chemotherapy Efficacy.
*Ware, M. A., Jensen, D., Barrette, A., Vernec, A., & Derman, W. (2018, September). Cannabis and the Health and Performance of the Elite Athlete.
*What is ADHD? | Centers For Disease Control and Prevention. CDC. Webpage.
*What is Eczema? National Eczema Association. Webpage.
*What Is Peripheral Neuropathy? | Living With Peripheral Neuropathy. (2019). Foundation for Peripheral Neuropathy. Webpage.
*What is Prohibited. (2018.). World Anti-Doping Agency. Webpage.
*What is psoriasis? American Academy of Dermatology. Webpage.
*Wilkinson, J., & Williamson, E. (2007). Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.
*Wing, S. H., & Mellanie, K. (2017, July). Cannabinoids in the Cardiovascular System.
*Wright, K. L., Duncan, M., & Sharkey, K. A. (2008, January). Cannabinoid CB2 receptors in the gastrointestinal tract: A regulatory system in states of inflammation.
*Xiong, W., Cui, T., Cheng, K., Fei Yang, S. C., Willenbring, D., Yun Guan, H. P., … Zhang, L. (2012, June). Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors.
*Zuardi, A. (2012). A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational Investigation.
*Zurier, R., & Burstein, S. (2016, November). Cannabinoids, Inflammation, and Fibrosis.
Article Updated: 10/30/2019 22:53:00 EST